Infection Control Today

Shingles Vaccine Doesn't Increase Risk in Taking Biologics for Autoimmune and Inflammatory Diseases

The live attenuated shingles (herpes zoster) vaccine (Zostavax®) does not appear to increase the short-term risk of developing shingles infection in people taking biologics for autoimmune and inflammatory diseases, according to research presented this week at the American ...More

November 7, 2011

Posted in News, Infections & Pathogens

Shingles May be Related to Elevated Risk of Multiple Sclerosis

Taiwanese investigators have found that there can be a significantly higher risk of multiple sclerosis (MS) occurring in the year following a shingles, or herpes zoster, attack. The findings, which support a long-held view on how MS may develop, are published in the Journal ...More

June 8, 2011

Posted in News

Study Challenges Concerns About Administering Pneumococcal and Shingles Vaccines Together

Administering both the pneumococcal and the herpes zoster vaccines to patients during the same visit is beneficial and does not appear to compromise the protective effect of the zoster vaccine, according to a Kaiser Permanente study published in the journal Vaccine. The ...More

May 16, 2011

Posted in News

UGA Compound Offers New Hope for Treatment of Adult Shingles

Researchers at the University of Georgia and Yale University have discovered a compound with the potential to be more effective than existing agents in treating the very painful blisters known as shingles—a condition that affects up to 30 percent of Americans, mostly ...More

April 21, 2011

Posted in News

FDA Approves Zostavax Vaccine to Prevent Shingles in Individuals Age 50-59

The Food and Drug Administration (FDA) today approved the use of Zostavax, a live attenuated virus vaccine, for the prevention of shingles in individuals 50 to 59 years of age. Zostavax is already approved for use in individuals 60 years of age and older. In the United ...More

March 25, 2011

Posted in News

New Study Alters Long-Held Beliefs About Shingles

For decades, medical wisdom about shingles has been that it’s a once-in-a-lifetime experience. The commonly-held belief is that patients are protected from a recurrence of the herpes zoster virus, which causes shingles, after one episode. But according to a study published ...More

February 1, 2011

Posted in News

Shingles Vaccine Associated With 55 Percent Reduced Risk of Disease

Receiving the herpes zoster vaccine was associated with a 55 percent reduced risk of developing shingles, according to a Kaiser Permanente study of 300,000 people that appears in the current issue of the Journal of the American Medical Association. This retrospective study ...More

January 12, 2011

Posted in News

Most Seniors Don't Get Shingles Vaccination, CDC Finds

Although a vaccine to prevent shingles has been available since 2006, less than 7 percent of U.S. seniors — the demographic most frequently affected by the disease — chose to receive the vaccination as of 2008, finds a new study from the Centers for Disease Control and ...More

January 11, 2011

Posted in News

Study Shows ZOSTAVAX Reduced Incidence of Shingles in Middle-Aged Adults by Nearly 70 Percent

In a large clinical study of adults ages 50 to 59, ZOSTAVAX® (Zoster Vaccine Live), Merck's vaccine for the prevention of shingles (herpes zoster), reduced the incidence of shingles by nearly 70 percent (69.8) compared to placebo. These new data were presented at the 48th ...More

October 26, 2010

Posted in News

Combination MMRV Vaccine Linked to Seizure Risk

The combination vaccine for measles, mumps, rubella and chickenpox (MMRV) is associated with double the risk of febrile seizures for 1- to 2-year-old children compared with same-day administration of the separate vaccine for MMR (measles, mumps, rubella) and the varicella ...More

June 28, 2010

Posted in News

ANTIMICROBIAL PRODUCTS	DISINFECTION/STERILIZA...
DISPOSABLE PRODUCTS	INFECTION CONTROL
LATEX-FREE PRODUCTS	More Options...

Shingles

Galleries

ICT Poll

Most Popular Articles

Buyer's Guide

Resources

Free Email Updates

featured links

First Name	Last Name
E-Mail